GenScript - Make Research Easy - The leader in molecular cloning and gene synthesis, peptide synthesis,protein and antibody engineering.

Structure-Based Design of Altered MHC Class II-Restricted Peptide Ligands with Heterogeneous Immunogenicity.

Authors: Chen S, Li Y, Depontieu FR, McMiller TL, English AM, Shabanowitz J, Kos F, Sidney J, Sette A, Rosenberg SA, Hunt DF, Mariuzza RA, Topalian SL.

Journal: J Immunol.

PubMed ID: 24108701

Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization.

Authors: Saenz R, Messmer B, Futalan D, Tor Y, Larsson M, Daniels G, Esener S, Messmer D.

Journal: Mol Immunol. 57(2):191-199

PubMed ID: 24172222

Control of SIV replication by vaccine-induced Gag-and Vif-specific CD8+ T cells.

Authors: Iwamoto N, Takahashi N, Seki S, Nomura T, Yamamoto H, Inoue M, Shu T, Naruse TK, Kimura A, Matano T.

Journal: J Virol.

PubMed ID: 24155398

MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia.

Authors: Cobbold M, De La Peña H, Norris A, Polefrone JM, Qian J, English AM, Cummings KL, Penny S, Turner JE, Cottine J, Abelin JG, Malaker SA, Zarling AL, Huang HW, Goodyear O, Freeman SD, Shabanowitz J, Pratt G, Craddock C, Williams ME, Hunt DF, Engelhard VH.

Journal: Sci Transl Med. 5(203):203ra125

PubMed ID: 24048523

MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides.

Authors: Braendstrup P, Justesen S, Østerbye T, Nielsen LLB, Mallone R.

Journal: PLoS One. 8(9):e73648

P2X7 Receptor Activation Impairs Exogenous MHC Class I Oligopeptides Presentation in Antigen Presenting Cells.

Authors: Alberto Baroja-Mazo, Maria BarberÀ-Cremades, Pablo PelegrÍn.

Journal: PLoS One. 8(8):e70577

Proline substitution independently enhances H-2Db complex stabilization and TCR recognition of melanoma-associated peptides.

Authors: Uchtenhagen H, Abualrous ET, Stahl E, Allerbring EB, Sluijter M, Zacharias M, Sandalova T, van Hall T, Springer S, Nygren PA, Achour A.

Journal: Eur J Immunol.

PubMed ID: 23939911

SOCS1 Prevents Potentially Skin-Reactive Cytotoxic T Lymphocytes from Gaining the Ability to Cause Inflammatory Lesions.

Authors: Rodriguez GM, D'Urbano D, Bobbala D, Chen XL, Yeganeh M, Ramanathan S, Ilangumaran S.

Journal: J Invest Dermatol. 133(8):2013-22

PubMed ID: 23443260

Peptide Modulation of Class I Major Histocompatibility Complex Protein Molecular Flexibility and the Implications for Immune Recognition.

Authors: Hawse WF, Gloor BE, Ayers CM, Kho K, Nuter E, Baker BM.

Journal: J Biol Chem.

PubMed ID: 23836912

Nanoscale Artificial Antigen Presenting Cells for T Cell Immunotherapy.

Authors: K Perica, A De LeÓn Medero, M Durai, YL Chiu, Joan Glick Bieler, Leah Sibener, Michaela Niemöller, Mario Assenmacher, Anne Richter, Michael Edidin, Mathias Oelke, Jonathan Schneck.

Journal: Nanomedicine.

全部